Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Total Liabilities (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Total Liabilities for 15 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 32.52% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Oct 2025, down 32.52%, and an annual FY2025 reading of $1.7 million, down 32.52% over the prior year.
  • Total Liabilities was $1.7 million for Q4 2025 at Pharma-Bio Serv, up from $1.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $8.9 million in Q1 2021 and bottomed at $1.7 million in Q3 2025.
  • Average Total Liabilities over 5 years is $4.0 million, with a median of $4.1 million recorded in 2022.
  • The sharpest move saw Total Liabilities surged 77.14% in 2021, then plummeted 47.86% in 2022.
  • Year by year, Total Liabilities stood at $5.0 million in 2021, then dropped by 18.25% to $4.1 million in 2022, then decreased by 7.77% to $3.8 million in 2023, then tumbled by 31.74% to $2.6 million in 2024, then tumbled by 32.52% to $1.7 million in 2025.
  • Business Quant data shows Total Liabilities for PBSV at $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.8 million in Q2 2025.